Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.
Tascini
C
C
Menichetti
F
F
Bozza
S
S
Del Favero
A
A
Bistoni
F
F
D000150:Acinetobacter / Q000187:drug effects*; D000151:Acinetobacter Infections / Q000382:microbiology; D000667:Ampicillin / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011112:Polymyxin B / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013407:Sulbactam / Q000494:pharmacology
C035444:sultamicillin; D000667:Ampicillin; D011112:Polymyxin B; D013407:Sulbactam; D012293:Rifampin